Stand Up To Cancer (SU2C) funds and develops the newest and most promising cancer treatments to help patients today. SU2C dramatically accelerates the rate of new discoveries by connecting top scientists in unprecedented collaborations to create breakthroughs. SU2C innovations lead to better cancer prevention, diagnosis, and treatment, which means that we can help save lives now.

Today alone, 5,200 people in the United States will be diagnosed with cancer. Progress against one type of cancer is progress against ALL cancer. That’s why we’re committed to funding ambitious and robust research and awareness efforts focused on incorporating health equity in cancer care, for the benefit of all patients facing cancer.

100% of your donation received supports Stand Up To Cancer and its collaborative cancer research programs.

Our Unique Approach

Historically, scientists have worked independently on different pieces of the cancer puzzle or have studied the same cancer questions without coordinating their efforts or sharing data. SU2C funds multidisciplinary, multi-institutional, collaborative research projects that address critical problems in cancer prevention, diagnosis, and treatment to deliver near-term patient benefit. This innovative approach is continuing to transform cutting-edge research and treatment breakthroughs in cancer. Additionally, since January 2020, SU2C requires that all grant proposals address the recruitment and retention of patients from medically underserved communities.

Collaboration

SU2C’s unique funding model mandates collaboration and innovation among our researchers and includes more than 3,000 scientists across more than 210 institutions.

Acceleration

SU2C funds scientifically rigorous, patient-focused research to accelerate the development of new treatments for people with cancer. The SU2C research portfolio includes 130 collaborative research teams, as well as 93 individual early-career investigators to bring new scientists and their ideas into cancer research.

Breakthrough Research

By innovating new ways for researchers to work together and providing substantial funding to deliver results, SU2C makes breakthroughs happen.

SU2C-supported research has already led to 9 new FDA-approved cancer treatments.